Dipeptidyl peptidase IV (DPPIV/CD26) inhibition does not improve engraftment of unfractionated syngeneic or allogeneic bone marrow after nonmyeloablative conditioning

In order to develop minimally toxic bone marrow transplantation (BMT) protocols suitable for use in a wider range of indications, it is important to identify ways to enhance BM engraftment at a given level of recipient conditioning. CXCL12/stromal cell-derived factor-1α plays a crucial physiological...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Schwaiger, Elisabeth, Klaus, Christoph, Matheeussen, Veerle, Baranyi, Ulrike, Pilat, Nina, Ramsey, Haley, Korom, Stephan, De Meester, Ingrid, Wekerle, Thomas
Format: Artigo
Idioma:Inglês
Publicat: Elsevier Science Inc 2012
Matèries:
Experimental Stem Cell Transplantation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3265670/
https://ncbi.nlm.nih.gov/pubmed/22085453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.exphem.2011.10.010
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars